Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women.
Apicella C, Dowty JG, Dite GS, Jenkins MA, Senie RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes WD, Hopper JL. Apicella C, et al. Among authors: foulkes wd. Clin Genet. 2007 Aug;72(2):87-97. doi: 10.1111/j.1399-0004.2007.00841.x. Clin Genet. 2007. PMID: 17661812
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA. Phelan CM, et al. Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120. Nat Genet. 1996. PMID: 8673090
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al. Tonin P, et al. Among authors: foulkes wd. Nat Med. 1996 Nov;2(11):1179-83. doi: 10.1038/nm1196-1179. Nat Med. 1996. PMID: 8898735 Review. No abstract available.
Is hereditary site-specific ovarian cancer a distinct genetic condition?
Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD. Liede A, et al. Among authors: foulkes wd. Am J Med Genet. 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r. Am J Med Genet. 1998. PMID: 9450858
The APCI1307K allele and breast cancer risk.
Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King MC, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W, Offit K. Redston M, et al. Nat Genet. 1998 Sep;20(1):13-4. doi: 10.1038/1666. Nat Genet. 1998. PMID: 9731522 No abstract available.
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. Warner E, et al. J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7. doi: 10.1093/jnci/91.14.1241. J Natl Cancer Inst. 1999. PMID: 10413426
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Jernström H, et al. Among authors: foulkes wd. Lancet. 1999 Nov 27;354(9193):1846-50. doi: 10.1016/s0140-6736(99)04336-6. Lancet. 1999. PMID: 10584720 Free article.
735 results